BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11734070)

  • 21. Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.
    Jawahar S; Tricoche N; Bulman CA; Sakanari J; Lustigman S
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009064. PubMed ID: 33600426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined benefits of annual mass treatment with ivermectin and cattle zooprophylaxis on the severity of human onchocerciasis in northern Cameroon.
    Seidenfaden R; Fischer A; Bonow I; Ekale D; Tanya V; Renz A
    Trop Med Int Health; 2001 Sep; 6(9):715-25. PubMed ID: 11555439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of onchocerciasis.
    Van Laethem Y; Lopes C
    Drugs; 1996 Dec; 52(6):861-9. PubMed ID: 8957156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda.
    Jacob BG; Loum D; Lakwo TL; Katholi CR; Habomugisha P; Byamukama E; Tukahebwa E; Cupp EW; Unnasch TR
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006702. PubMed ID: 30148838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of onchocerciasis today: status and challenges.
    Richards FO; Boatin B; Sauerbrey M; Sékétéli A
    Trends Parasitol; 2001 Dec; 17(12):558-63. PubMed ID: 11756018
    [No Abstract]   [Full Text] [Related]  

  • 26. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
    Senyonjo L; Oye J; Bakajika D; Biholong B; Tekle A; Boakye D; Schmidt E; Elhassan E
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004905. PubMed ID: 27529622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness.
    Bhattacharyya S; Vinkeles Melchers NVS; Siewe Fodjo JN; Vutha A; Coffeng LE; Logora MY; Colebunders R; Stolk WA
    PLoS Negl Trop Dis; 2023 May; 17(5):e0011320. PubMed ID: 37235598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.
    Duerr HP; Raddatz G; Eichner M
    Int J Parasitol; 2011 Apr; 41(5):581-9. PubMed ID: 21255577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.
    Hoerauf A; Mand S; Adjei O; Fleischer B; Büttner DW
    Lancet; 2001 May; 357(9266):1415-6. PubMed ID: 11356444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mectizan and onchocerciasis: 10 years of Mectizan in Africa, a partnership for prolonged success].
    Pacqué M
    Sante; 1998; 8(1):77-8. PubMed ID: 9592889
    [No Abstract]   [Full Text] [Related]  

  • 31. Transmission of Onchocerca volvulus and prospects for the elimination of its vector, the blackfly Simulium neavei in the Mpamba-Nkusi focus in Western Uganda.
    Lakwo TL; Ndyomugyenyi R; Onapa AW; Twebaze C
    Med Vet Entomol; 2006 Mar; 20(1):93-101. PubMed ID: 16608493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling targeted ivermectin treatment for controlling river blindness.
    Poolman EM; Galvani AP
    Am J Trop Med Hyg; 2006 Nov; 75(5):921-7. PubMed ID: 17123988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of Mectizan on the transmission of onchocerciasis.
    Boatin BA; Hougard JM; Alley ES; Akpoboua LK; Yaméogo L; Dembélé N; Sékétéli A; Dadzie KY
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S46-60. PubMed ID: 9861267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone.
    Richards F; Rizzo N; Diaz Espinoza CE; Monroy ZM; Crovella Valdez CG; de Cabrera RM; de Leon O; Zea-Flores G; Sauerbrey M; Morales AL; Rios D; Unnasch TR; Hassan HK; Klein R; Eberhard M; Cupp E; Domínguez A
    Am J Trop Med Hyg; 2015 Dec; 93(6):1295-304. PubMed ID: 26503275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.
    Verver S; Walker M; Kim YE; Fobi G; Tekle AH; Zouré HGM; Wanji S; Boakye DA; Kuesel AC; de Vlas SJ; Boussinesq M; Basáñez MG; Stolk WA
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S267-S274. PubMed ID: 29860291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flubendazole as a macrofilaricide: History and background.
    Geary TG; Mackenzie CD; Silber SA
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006436. PubMed ID: 30650160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting onchocerciasis transmission: lessons for infection control.
    Cheke RA
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):377-386. PubMed ID: 28117596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onchocerciasis control in Ghana (1974-2016).
    Biritwum NK; de Souza DK; Asiedu O; Marfo B; Amazigo UV; Gyapong JO
    Parasit Vectors; 2021 Jan; 14(1):3. PubMed ID: 33388081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
    Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
    Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of Ethiopian Onchocerciasis Elimination Programme.
    Meribo K; Kebede B; Feleke SM; Mengistu B; Mulugeta A; Sileshi M; Samuel A; Deribe K; Tadesse Z
    Ethiop Med J; 2017; 55(Suppl 1):55-63. PubMed ID: 28878430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.